Connect with us

Biotech

Extremadura Subsidizes R&D&I Projects for Covid-19 Containment with €3 million

As a whole, with the resolution of the two calls that have been approved for the sanitary containment of the Covid-19, the Regional Government of Extremadura has led, in the field of R&D&I, a total of 13 projects (three related to industrial research and experimental development and another ten referred to investments for the acquisition of equipment), for 5.4 million (€4.6 million).

Published

on

Extremadura puts more emphasis on the containment of the new coronavirus. The Regional Ministry of Economy, Science and Digital Agenda, through the General Secretariat of Science, Technology, Innovation, and University, has approved six research, development, and innovation (R&D&I) projects aimed at containing Covid-19, which will be subsidized with $3.5 million (€3 million). In addition, they involve an investment by the beneficiary companies of $4.7 million (€4 million) and the obligation to create 19 direct jobs.

Most of the projects that have obtained subsidies are related to the acquisition of equipment and investment goods based on innovative technology for the assembly of production lines for hydroalcoholic gels, hygienic masks, and other textile elements for protection against the virus. However, new in this edition is a project based on the acquisition of equipment for the manufacture of nitrile gloves and another for the manufacture of special food or food supplements for hospitalized patients.

These projects are the result of this year’s call for extraordinary grants for Covid-19 health containment, which was approved by Resolution of April 27th, 2021, under the Order of June 26th, 2020, of the Regional Ministry of Economy, Science and Digital Agenda.

If you want to read more about Extremadura and the fight to halt the new coronavirus pandemic, download for free our companion app. The Born2Invest mobile app brings you the most important finance headlines in the world so you can stay on top of the market.

Extremadura has led, in the field of R&D&I, a total of 13 projects for the containment of the coronavirus

As a whole, with the resolution of the two calls that have been approved for the sanitary containment of the Covid-19, the Regional Government of Extremadura has led, in the field of R&D&I, a total of 13 projects (three related to industrial research and experimental development and another ten referred to investments for the acquisition of equipment), for 5.4 million (€4.6 million).

SEE ALSO  Nexi and Bain signed a strategic partnership for open banking

These grants have financing that can range from 80% to 100%, charged to the Operational Program of the European Regional Development Fund (Feder) of Extremadura corresponding to the 2014-2020 programming period.

The Secretary-General of Science, Technology, Innovation and University, Jesús Alonso, has highlighted the importance of these grants insofar as they contribute to positioning Extremadura in the fight against the health pandemic and its effects, favor economic recovery, business investment, the application of technological innovation to the productive system and the creation of jobs associated to these investments.

According to Alonso, this type of investment will be promoted during the next years under the Operational Program for Extremadura during the period 2021-2027, up to the amount allowed by the Community rules outside the Temporary National Framework.

__

(Featured image by fernandozhiminaicela via Pixabay)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in PlantaDoce, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Anthony Donaghue writes about science and technology. Keeping abreast of the latest tech developments in various sectors, he has a keen interest on startups, especially inside and outside of Silicon Valley. From time to time, he also covers agritech and biotech, as well as consumer electronics, IT, AI, and fintech, among others. He has also written about IPOs, cannabis, and investing.